Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

KVA

K V Pharma CL A (KVA)

K V Pharma CL A
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:KVA
日付受信時刻ニュースソース見出しコード企業名
2012/06/1822 : 04Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
2012/06/1820 : 08Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
2011/11/1710 : 15Business WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
2011/11/0310 : 40Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
2011/11/0110 : 30Business WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
2011/10/2905 : 30Business WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
2011/10/2502 : 52Business WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
2011/10/2109 : 47Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
2011/10/1322 : 02Business WireZeldes & Haeggquist, LLP Announces Investigation of K-V PharmaceuticalNYSE:KVAK V Pharma CL A
2011/06/1321 : 00PR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVAK V Pharma CL A
2011/04/0204 : 08Dow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVAK V Pharma CL A
2011/04/0123 : 28Dow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVAK V Pharma CL A
2011/04/0106 : 28Dow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVAK V Pharma CL A
2011/03/3104 : 58Dow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
2011/03/3101 : 38Dow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
2011/03/0122 : 49PR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVAK V Pharma CL A
2011/02/1500 : 36PR Newswire (US)KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call CommentsNYSE:KVAK V Pharma CL A
2011/02/1500 : 34PR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVAK V Pharma CL A
2011/02/1423 : 48PR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVAK V Pharma CL A
2011/02/0422 : 40PR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVAK V Pharma CL A
2011/01/1223 : 03PR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™NYSE:KVAK V Pharma CL A
2010/09/1423 : 29Dow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVAK V Pharma CL A
2010/09/1022 : 53Dow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVAK V Pharma CL A
2010/02/2603 : 53PR Newswire (US)KV Pharmaceutical Reaches Agreement with U.S. Department of JusticeNYSE:KVAN^CURN
2010/01/2907 : 04Business WireRobbins Umeda LLP Announces Investigation of KV Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
2010/01/2105 : 41Dow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVAK V Pharma CL A
2010/01/2104 : 11Dow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVAK V Pharma CL A
2010/01/1123 : 18PR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVA
2010/01/0806 : 10PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVA
2009/12/2307 : 34PR Newswire (US)KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010NYSE:KVA
 Showing the most relevant articles for your search:NYSE:KVA

最近閲覧した銘柄

Delayed Upgrade Clock